BCR and hematopoietic and lymphoid cell neoplasm: This work represents the first major use of NGS to profile the complete BCR repertoire in healthy dogs and dogs undergoing treatment for intermediate-to-large B-cell lymphoma, a common canine hematopoietic neoplasm that we used as a model for B-cell clonality.